Neurolink
Neurolink is an early-stage company developing a novel therapy for the treatment of epilepsy.
Neurolink is a company in biotechnology, pharmaceutical, therapeutics based in Southern US, founded in 2008.
The company sits in the biotechnology, pharmaceutical, therapeutics segment, where it competes on its core product or service.
Its base of operations is Southern US.
It is recorded at the Series_Unknown stage.
Its team size is recorded as c_00011_00050 employees.
Public records show total funding of about $3.9M.
| Sector | Biotechnology, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Southern US |
| Founded | 2008 |
| Employees | c_00011_00050 |
| Stage | series_unknown |
| Total funding | $3,878,759 |
Website: neurolinkmedical.com
Sign in to view the contact information we hold for Neurolink.
Create a free account
Create a free account